Cargando…

Studies on Prostaglandin-Endoperoxide Synthase 1: Lower Levels in Schizophrenia and After Treatment with Antipsychotic Drugs in Conjunction with Aspirin

BACKGROUND: Antipsychotic drugs plus aspirin (acetylsalicylic acid), which targets prostaglandin-endoperoxide synthase 1 (PTGS1: COX1), improved therapeutic outcomes when treating schizophrenia. Our microarray data showed higher levels of PTGS1 mRNA in the dorsolateral prefrontal cortex from subject...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dean, Brian, Gibbons, Andrew, Gogos, Andrea, Udawela, Madhara, Thomas, Elizabeth, Scarr, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Regular Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838806/ https://www.ncbi.nlm.nih.gov/pubmed/30052978 http://dx.doi.org/10.1093/ijnp/pyx092

Ejemplares similares

Validating reference genes using minimally transformed qpcr data: findings in human cortex and outcomes in schizophrenia
por: Dean, Brian, et al.
Publicado: (2016)

Changed frontal pole gene expression suggest altered interplay between neurotransmitter, developmental, and inflammatory pathways in schizophrenia
por: Scarr, Elizabeth, et al.
Publicado: (2018)

PM483. Gene expression changes in the rat frontal cortex caused by sex steroid hormones
por: Gogos, Andrea, et al.
Publicado: (2016)

A Role for Estrogen in Schizophrenia: Clinical and Preclinical Findings
por: Gogos, Andrea, et al.
Publicado: (2015)

Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia
por: Gibbons, Andrew, et al.
Publicado: (2018)

Cholinergic connectivity: it's implications for psychiatric disorders
por: Scarr, Elizabeth, et al.
Publicado: (2013)

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
por: Parkin, Georgia M, et al.
Publicado: (2018)

Common Variants of the Prostaglandin-Endoperoxide Synthase 2 Gene and Hepatocellular Carcinoma Susceptibility
por: Li, Hong-guang, et al.
Publicado: (2015)

Post-translational modifications of prostaglandin-endoperoxide synthase 2 in colorectal cancer: An update
por: Jaén, Rafael I, et al.
Publicado: (2018)

In vitro functional characterization of prostaglandin-endoperoxide synthase 2 during chondrocyte hypertrophic differentiation
por: Li, Na, et al.
Publicado: (2016)

The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer
por: Lin, Xiao-mian, et al.
Publicado: (2019)

Nitroarachidonic Acid, a Novel Peroxidase Inhibitor of Prostaglandin Endoperoxide H Synthases 1 and 2
por: Trostchansky, Andrés, et al.
Publicado: (2011)

Human parathyroid hormone fragment stimulates the de novo synthesis of prostaglandin endoperoxide synthase in chick calvaria
por: Yang, Chin-Yuh, et al.
Publicado: (1993)

Prognostic Value of Prostaglandin-endoperoxide Synthase 2 Polymorphisms in Prostate Cancer Recurrence after Radical Prostatectomy
por: Lee, Cheng-Hsueh, et al.
Publicado: (2016)

Modulation of the prostaglandin-endoperoxide synthase 2 gene expression by variant haplotypes: influence of the 3′-untranslated region
por: Piranda, D.N., et al.
Publicado: (2017)

Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach
por: Saindane, Madhuri, et al.
Publicado: (2020)

Increased cortical expression of the zinc transporter SLC39A12 suggests a breakdown in zinc cellular homeostasis as part of the pathophysiology of schizophrenia
por: Scarr, Elizabeth, et al.
Publicado: (2016)

Assessment of Prostaglandin-Endoperoxide Synthase 2 and Versican gene expression profile from the cumulus cells: association with better in vitro fertilization outcomes
por: Ocampo, Azucena, et al.
Publicado: (2018)

Characterization of an AM404 Analogue, N-(3-Hydroxyphenyl)arachidonoylamide, as a Substrate and Inactivator of Prostaglandin Endoperoxide Synthase
por: Turman, Melissa V., et al.
Publicado: (2009)

A fluorescence microscopy method for quantifying levels of prostaglandin endoperoxide H synthase-1 and CD-41 in MEG-01 cells
por: Franks, Douglas J, et al.
Publicado: (2001)

The Bradykinin System Contributes to the Regulation of Prostaglandin-Endoperoxide Synthase 2 Expression in Human Amnion Fibroblasts: Implications for Term and Preterm Birth
por: Ni, Xiao-tian, et al.
Publicado: (2022)

The Impact of Removal of Ovarian Hormones on Cholinergic Muscarinic Receptors: Examining Prepulse Inhibition and Receptor Binding
por: Ch’ng, Sarah S., et al.
Publicado: (2020)

Evidence for impaired glucose metabolism in the striatum, obtained postmortem, from some subjects with schizophrenia
por: Dean, B, et al.
Publicado: (2016)

miR-103 Promotes Neurite Outgrowth and Suppresses Cells Apoptosis by Targeting Prostaglandin-Endoperoxide Synthase 2 in Cellular Models of Alzheimer’s Disease
por: Yang, Hui, et al.
Publicado: (2018)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

Low Density Lipoprotein Receptor-Related Protein and Apolipoprotein E Expression is Altered in Schizophrenia
por: Gibbons, Andrew Stuart, et al.
Publicado: (2010)

Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor
por: Scarr, E, et al.
Publicado: (2018)

Autophagy has a key role in the pathophysiology of schizophrenia
por: Merenlender-Wagner, A, et al.
Publicado: (2015)

Altered Neuronal Markers Following Treatment with Mood Stabilizer and Antipsychotic Drugs Indicate an Increased Likelihood of Neurotransmitter Release
por: Scarr, Elizabeth, et al.
Publicado: (2012)

Prostaglandin-endoperoxide synthase 2 (PTGS2) gene expression and its association with genes regulating the VEGF signaling pathway in head and neck squamous cell carcinoma
por: Kamal, Mehta Vedant, et al.
Publicado: (2023)

Outpatient Antipsychotic Treatment and Inpatient Costs of Schizophrenia
por: Marcus, Steven C., et al.
Publicado: (2008)

SELENBP1 expression in the prefrontal cortex of subjects with schizophrenia
por: Udawela, M, et al.
Publicado: (2015)

Marine Terpenic Endoperoxides
por: Torres-García, Irene, et al.
Publicado: (2021)

Widespread Changes in Positive Allosteric Modulation of the Muscarinic M(1) Receptor in Some Participants With Schizophrenia
por: Hopper, Shaun, et al.
Publicado: (2019)

A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study
por: Cox, David G, et al.
Publicado: (2007)

The therapeutic effect of miR-125b is enhanced by the prostaglandin endoperoxide synthase 2/cyclooxygenase 2 blockade and hampers ETS1 in the context of the microenvironment of bone metastasis
por: Maroni, Paola, et al.
Publicado: (2018)

Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia
por: Lieslehto, Johannes, et al.
Publicado: (2022)

PM490. Upregulation of zinc transporter, solute carrier family 39, member 12, in the cortex of subjects with schizophrenia
por: Udawela, M, et al.
Publicado: (2016)

Immunohistochemical Demonstration of Membrane-bound Prostaglandin E(2) Synthase-1 in Papillary Thyroid Carcinoma
por: Omi, Yoko, et al.
Publicado: (2009)

Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics
por: Lin, Ching-Hua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vu14n5p1gf2kan05jbflsv5og1